NCT07730515
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Lymphoma, T-Cell, Peripheral
Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.
235 public trials
60 recruiting studies
Lymphoma, T-Cell, Peripheral trial results
NCT04045470
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
NCT06072131
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of California, San Francisco Fresno Clovis, California, United States
- University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600 Santa Monica, California, United States
- University of Colorado School of Medicine Aurora, Colorado, United States
- Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute Pembroke Pines, Florida, United States
Recruiting
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
NCT06176690
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type, +17 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT05833724
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
- Far eastern memorial hospital New Taipei City, Taiwan
- Taichung Veterans General Hospital Taichung, Taiwan
NCT06508463
- Conditions
- Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT07195916
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
- University of Michigan Ann Arbor, Michigan, United States
- The University of Nebraska Medical Center Omaha, Nebraska, United States
NCT04068597
- Conditions
- Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +27 more
- Locations
-
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- Community Health Network Indianapolis, Indiana, United States
- The Center for Cancer and Blood Disorders (CCBD) Bethesda, Maryland, United States
- Nebraska Cancer Specialists Omaha, Nebraska, United States
Recruiting
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
NCT05313243
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Yale Smilow Cancer Hospital New Haven, Connecticut, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States